This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September 2026 quarter revenue rises 31.5 percent year on year; profit turns positive
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 6.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue from operations for the quarter ended 30 September 2026 was Rs 3,282.89 lakh, up 31.5 percent from Rs 2,496.02 lakh a year earlier; profit after tax was Rs 50.63 lakh versus a loss of Rs 19.77 lakh. An exceptional charge was reported. Consolidated half-year operating cash flow was an outflow of Rs 947.32 lakh. The board appointed Pardeep Kumar Bhardwaj as an additional independent director, pending shareholder approval.
Revenue growth and a return to quarterly profit help, but negative operating cash flow and exceptional charges keep near-term risk elevated.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹21.83 Cr | ₹22.28 Cr | −2.0% |
| Operating profit | −₹1.64 Cr | −₹1.15 Cr | loss widened |
| Profit after tax | ₹0.51 Cr | −₹0.20 Cr | turned positive |
| EBITDA margin | 2.3% | 4.1% | −1.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.